Editor in Chief
John W. Oller, Jr., PhD in General Linguistics from the University of Rochester in New York, is Professor Emeritus, Department of Linguistics, University of New Mexico in Albuquerque. He formerly served as a tenured faculty member consecutively at the University of California at Los Angeles, the University of New Mexico, and the University of Louisiana. He is an experimentalist and theoretician with expertise in information theory and in the development of language and biosignaling systems across time, especially, how they are impacted by toxicants, traumatic injuries (macro or micro), pathogens, emotional stress, and the interactions of injurious factors leading to breakdowns, disorders, diseases, and death, mailto: [email protected]
Christopher A. Shaw, PhD, Professor, Department of Ophthalmology, University of British Columbia, 828 W. 10th Ave, Vancouver, BC, V5Z 1L8 expertise in the dynamics of neurological disease and in experimental modeling of the impact of toxicants such as aluminum adjuvants on mouse and human biochemistry; mailto: [email protected]
Allison E. Bakovic, PhD in biosciences specializing in virology and infectious diseases (winner of the George Mason University Best Doctorate of Philosophy Dissertation 2021); BS in biomolecular engineering; previously a graduate research assistant at the National Center for Biodefense and Infectious Diseases in Manassas, Virginia; specializing in protein-protein interactions, kinetic modelling of interactomes, viral replication mechanisms, and therapeutic interventions as medical countermeasure strategies for RNA viruses, including SARS-CoV-2 and a variety of alphaviruses; see her publications in PubMed Central.
Russell Blaylock, MD, nationally recognized board-certified neurosurgeon, health practitioner, author, and lecturer; practiced 26 years in neurosurgery; serves as Associated Editor-in-Chief of the Neuroinflammation Section of Surgical Neurology International
Daniel Broudy, PhD, professor of rhetoric and applied linguistics at Okinawa Christian University, holds a doctorate in applied psycholinguistics from the School of Communication and Creative Arts at Deakin University, and integrates research in cognitive linguistics, developmental and social psychology, semiotics, and communication theory as an effort to describe ways in which power centers organize campaigns of persuasion and engineer consent for policies and actions across cultures.
Claudia Chaufan, MD (Argentina), PhD (Sociology/Philosophy, USA), is Associate Professor of Health Policy and Global Health at York University (Canada), past US Fulbright Scholar in Public/Global Health, and former Graduate Program Director in Health. Chaufan has published widely in academic and lay venues, and is an editorial board member and reviewer for various professional journals. She has been funded by the US National Institutes of Health (NIH), the Canadian Institute for Health Information (CIHI), and the Social Sciences and Humanities Research Council in Canada (SSHRC), and has taught at universities in Argentina, the USA, Taiwan, and Canada. Informed by clinical, sociological and philosophical training, her research is about determinants of health, the geopolitics of global health, focusing on how health narratives drive perceptions of risk, practices of stigmatization, and policies of exclusion. Current projects include the politics of sanctions policy, the geopolitics of Anti-Asian racism, and medicalization and social control in the COVID-19 era.
Robert M. Davidson, MD, PhD, Certified by the American Board of Nuclear Medicine 1990; also by the American Board of Internal Medicine 1996; Fellow of the American Institute of Stress; expertise in the broad spectrum of human biochemistry, toxicants, pharmaceuticals, vaccines, and medicine.
Antonietta Gatti, PhD, Doctorate also in Experimental Physics, Cofounder and Principal Investigator of Nanodiagnostics, SRL (Società a Responsabilità Limitata), Italy; expertise in biomaterials, electron microscopy, nanotechnologies, biomaterial degradation, induced pathologies, and tissue engineering to prevent biomaterial injuries; holds patent for material to detect phosphorus and calcium ions in polluted waters; winner of the GIRSO Prize 1987; author of 140+ peer-reviewed scientific publications.
Mary S. Holland, MA, JD, General Counsel for Children's Health Defense 2019-present; formerly Director Graduate Lawyering Program, New York University School of Law 2004-2019; expertise in children's health and litigation concerning vaccines; renowned author of works in that area.
Brian S. Hooker, PhD, PE, Children's Health Defense Chief Scientific Officer is Professor of Biology at Simpson University, Redding, California; has expertise in microbiology, biotechnology and chemistry. He served as senior research engineer at Pacific Northwest National Laboratory for 16 years and is co-inventor on 5 patented items; received Battelle Entrepreneurial Award in 2001 and Federal Laboratory Consortium Recognition Award 1999 for “Reactive Transport in 3-Dimensions”; authored 60+ peer-reviewed science and engineering papers; worked with CDC chief statistician and whistleblower, Dr. William Thompson, regarding so-called "vaccine safety research" forcing release of 10,000+ pages of documents showing fraud and corruption at the CDC.
J. J. Kartzinel, MD, Fellow of the American Academy of Pediatrics, Kartzinel Wellness Center; expertise as clinician practitioner treating autism and related neurological disorders.
Robert J. Krakow, JD, Law Office of Robert J. Krakow, Representing the Vaccine Injured in All 50 States.
David L. Lewis, PhD, Professor and Member of the Graduate Faculty, University of Georgia, Research Director at Focus for Health Science for Sale, Skyhorse Publishing Watchung, NJ, Winner of the Sierra Club Distinguished Service Award 2018; and Winner of the US EPA Science Achievement Award 2000; expertise in environmental health risks associated with vaccines.
James Lyons-Weiler, PhD, CEO, President and Director of the Institute for Pure and Applied Knowledge at the University of Pittsburgh, Pennsylvania; PhD in Ecology, Evolution & Conservation in Biology; postdoctoral fellow in Computational Molecular Biology at Pennsylvania State University; Senior Research Scientist, and Scientific Director in support of translational research, systems biology, sequence analysis, and algorithmic solutions for big data in bioinformatics; Editor-in-Chief of the journal Science, Public Health Policy, and the Law; research interests and published works cover autism/ASD, biomarker development for complex disorders, immunology, toxicology, cancer biology, cancer receptors, phased biomarker development, microarray data analysis, proteomic data analysis, machine-learning based prediction model optimization, and information theory.
Dana Butnaru Medis, MD, PhD in progress, founder of DANAMEDIS Institute of Immunological Research; expert in autoimmunity, neuroimmunology, immune-mediated female infertility, immunodeficiency and immuno-nutrition; her most recent ground-breaking work pertains to prion/prion-like disease involving protein misfolding particularly impacting the immunocompetence of the CNS by corrupting the microglia in a battleground of great importance to the post-COVID-19 world.
Stefano Montanari, Doctorate in Pharmacy with a dissertation in michrochemistry; Director of the Nanodiagnostics Laboratory of Modena since 2004, inventor of caval filtration devices, a prosthetic heart valve, and teacher on caval filtration and nanopathologies in the Interuniversity Masters in Nanotechology of Venice (Ca ’Foscari University, University of Padua, University of Verona), the University of Turin and the European Community; expertise in caval filtration and the prevention of pulmonary thromboembolism; and in pathologies induced by solid, inorganic nanoparticles.
Christof Plothe, DO, BSc, OST, HONS, MRO, DPO, HP Practice in Osteopathy, Bleichstraße 21, Alzey, Germany; practices in Ireland, the United States, Spain, and now Germany; author and co-author of books and articles about child birth hormones (oxytocin), toxicants, psychoactive pharmaceuticals, and disorders including autism.
Asgeir Saebo, MS in biology and chemistry University of Bergen, entrepreneur, widely published scientific author/inventor with 35 patents, and former President of American Oil Chemists Society.
Daniel Santiago, PharmD, bachelor of science concentration in molecular and genetic biology from Temple University in 1992, coursework in laboratory techniques in molecular biology and genetics at the University of Pennsylvania in Philadelphia, at the Wistar Institute in Philadelphia in 1992-1993, on a federal grant worked with Chin C. Howe, PhD, holder of the noted patent of the SPARC (secreted protein acidic cysteine-rich glycoprotein) deficient transgenic mouse; identified and characterized the promoter of the elongation factor-2 (EF-2) gene, essential for protein synthesis and helped Howe to map a region proximal to this promoter that drives ubiquitous expression and found it bound to a transcription factor producing DNA-protein complex; with his doctorate in pharmacy (PharmD) from Nova Southeastern University in Fort Lauderdale, Florida, he works for Publix Pharmacies.
Stephanie Seneff, PhD, Senior Research Scientist at the MIT Computer Science and Artificial Intelligence Laboratory (CSAIL), BS biophysics 1968, MS electrical engineering 1980, and PhD computer science in 1985, in addition to her interest in processing of natural sign systems, her current research has focusing on biosignaling systems and ways they are disrupted by toxicants and genetic engineering.
Tamara Tuuminen, MD, PhD, Adjunct professor at Kruunuhaka Medical Centre, Helsinki, and Mineraalilaboratorio Mila, Helsinki, is a specialist in clinical microbiology; in 1979, graduated from the 1st Moscow Medical Institute with an MD specializing in hygiene and epidemiology; in 1993, earned a PhD from the University of Helsinki and in 2006-2007 while practicing medical microbiology also taught in that field at the University of Helsinki; research advances include methods for the screening of new-borns for congenital hypothyroidism, phenylketonuria, and the use of ELISA serology to detect congenital toxoplasmosis, Chlamydia pneumoniae, Mycoplasma pneumoniae, and latent tuberculosis; taught virology, bacteriology, and immunology for a decade at the University of Helsinki and made advances in the detection and treatment of mould-related illness and clinical immuno-nutrition; supervised bioanalyst graduates at the master’s and doctoral levels and has authored about 100 original articles and reviews in international and Finnish medical journals, holds four patents and formerly served as chief physician in Mikkeli Central Hospital (Finland) in microbiology.
Leigh Willoughby, MD, specializing in functional medicine, with a career in anesthesiology, neuroanesthetics, mesenteric inflammatory signalling, gut-derived endothelial toxicity, and nonpharmacological treatments; served as Research Fellow in the Injury, Infection, and Inflammation Research Group at the Academic Health Sciences Centre of the University of Manchester, UK from 2003 - 2011; worked as Head of the Department of Anaesthesia at Tairawhiti District Health Board in New Zealand until 2022; and now focuses on directing the private medical clinic, Functional Again, Ltd., that she founded in Gisborne; that clinic delivers root-cause personalised medicine and brain integration therapies for developmental disorders and chronic health conditions.